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Summary
The telomere-stabilizing enzyme telomerase is induced in tumors and functionally associated with unlimited replicative
potential. To further explore its necessity, transgenic mice expressing SV40 or HPV16 oncogenes, which elicit carcinomas
in pancreas and skin, respectively, were rendered telomerase-deficient. Absence of telomerase had minimal impact on
tumorigenesis, even in terc/ generations (G5–7) exhibiting shortened telomeres and phenotypic abnormalities in multiple
organs. Analyses of chromosomal aberrations were not indicative of telomere dysfunction or increased genomic instability
in tumors. Quantitative image analysis of telomere repeat intensities comparing biopsies of skin hyperplasia, dysplasia,
and carcinoma revealed that telomere numbers and relative lengths were maintained during progression, implicating a
means for preserving telomere repeats and functionality in the absence of telomerase.
Introduction Nugent and Lundblad, 1998). Telomerase activity is normally
low or undetectable in somatic tissues as well as in primary
Telomeres are nucleoprotein structures at chromosomal ends cells in culture (Kim et al., 1994; Chadeneau et al., 1995). As a
consisting of short tandem DNA repeats bound by specific pro- result, telomere lengths are reduced with every cell division until
teins that function to maintain chromosomal integrity (Greider, a critical short length is reached, eliciting a senescent response
1996; Blackburn, 2001). Telomeric repeat DNA is synthesized (Harley et al., 1990). The short-telomere-mediated entry into
and maintained by telomerase, a specialized reverse tran- replicative senescence appears to require the action of the p53
and Rb tumor suppressor pathways (Counter et al., 1992; Shayscriptase composed of a catalytic subunit named TERT (tel-
omerase reverse transcriptase) that utilizes an RNA template et al., 1991; Shay and Wright, 1996). A second telomere-associ-
ated proliferation block, termed “crisis,” emerges as continuedknown as terc (telomerase RNA component) (Greider, 1998;
S I G N I F I C A N C E
Telomere shortening normally limits the replicative potential of cells, serving as a barrier to carcinogenesis, and activation of
telomerase is associated with malignancy in many human cancers. This study examined tumorigenesis in mice where telomerase
was absent and telomeres had become shortened and evidently dysfunctional in multiple tissues. Pancreatic islet and epidermal
squamous carcinomas developed normally in these mice, despite sterility, atrophy, and other telomere-associated abnormalities
in normally proliferative tissues. Thus, when viral oncoproteins commandeer multiple cellular functions, including the Rb and p53
tumor suppressors, tumorigenesis may not be so critically dependent on telomerase. This unexpected tolerance of shortened telomeres
and inactive telomerase by developing tumors may prove relevant to strategies aimed at inhibiting telomerase in certain human
cancer types.
CANCER CELL : OCTOBER 2004 · VOL. 6 · COPYRIGHT  2004 CELL PRESS 373
A R T I C L E
cell division leads to severe telomere erosion. During crisis, cells
suffer genomic instability and death; rare immortalized survivors
show restored telomere maintenance and function, most com-
monly via activation of telomerase activity (Shay et al., 1991;
Bodnar et al., 1998; Kiyono et al., 1998; Jiang et al., 1999;
Morales et al., 1999). Less commonly, telomere function can
be preserved through a telomerase-independent, alternative
mechanism of telomere maintenance (ALT) (Bryan et al., 1997;
Dunham et al., 2000) that may involve homologous recombina-
tion (Lundblad and Blackburn, 1993; McEachern and Blackburn,
1996; Nakamura et al., 1998; Teng and Zakian, 1999, Bechter
et al., 2003). In humans, increasing evidence suggests that tel-
omerase upregulation is important for carcinogenesis (Kim et
al., 1994; Hahn et al., 1999; Stewart and Weinberg, 2000; Blasco
and Hahn, 2003).
Telomerase-deficient mice have been generated via deletion
of the mouse terc gene encoding the RNA component of telome-
rase (Blasco et al., 1997). Terc/ mice show phenotypic abnor-
malities only after successive generations of terc/ intercrosses
(Lee et al., 1998; Rudolph et al., 1999). The normality of early
generation telomerase null mice is attributed to the relatively
long telomeres of laboratory mice, which are 20–50 kb in length,
compared with human telomere lengths ranging from 8–15 kb
(Kipling, 1997). Telomere shortening in late-generation terc/
mice is associated with a range of histopathological defects in
highly proliferative tissues, e.g., germ cell depletion in the testis,
uterine and intestinal atrophy, and impaired hematopoiesis.
Several studies have employed terc/ mice to examine the
impact of telomere dysfunction on tumorigenesis in vivo. Telo-
mere shortening was shown to modulate tumor phenotypes in
a complex manner, correlating with the functional status of the
p53 tumor suppressor (Chin et al., 1999; de Lange and DePinho,
1999; Artandi et al., 2000).
We have previously analyzed terc expression and telome-
rase activity in two different transgenic models of multistage
tumorigenesis (Blasco et al., 1996). Telomerase activity was
Figure 1. Late generation terc/ RIP1-Tag2 and K14-HPV16 mice evidenceupregulated in a majority of islet tumors in RIP1-Tag2 mice, and
telomere shortening and organismic telomere dysfunctionin high-grade squamous carcinomas in K14-HPV16 mice. Now,
A: A statistically significant decrease in testicular mass was observed forto assess the functional importance of telomerase and telomere
both terc/ RIP1-Tag2 (p  .0027) and terc/ HPV-16 (p  .0067) mice
status in these multistage tumorigenesis pathways, the terc relative to age-matched RIP1-Tag2 and HPV-16 Terc/ mice (Mann-Whit-
gene knockout was established in these lines, and tumor pheno- ney t test).
B: Mean telomere content for G0–3 versus G5–7 terc/ RIP1-Tag2 mice andtype assessed in successive generations of telomerase null
wt versus G6–7 terc/ K14-HPV16 mice was quantified by DNA slot blottingmice, as the constitutional telomere length was progressively
as described in the Experimental Procedures. Tail DNA showed a statisticallyshortened to dysfunctional lengths. Remarkably, the data pro-
significant decrease in mean telomere content in G5–7 RIP1-Tag2 terc/
vide evidence that telomerase activity is not essential for either mice (p  0.0221). A reduction in telomere content in tail DNA of G6–7 K14-
tumorigenesis pathway. HPV16 is suggested (although p  0.5160, which is not significant).
C: Quantitative image analysis of images produced by fluorescence in situ
hybridization (FISH) using a telomere repeat probe on liver tissue from wtResults
(terc/) and G5–7 terc/ HPV16 transgenic mice showed that telomere
numbers were similar if not slightly elevated in the G5–7 liver (left panel),
Effects of telomerase loss in late-generation terc/ whereas the average hybridization intensity per telomere was reduced
(right panel). (For telomere number, p  0.01; for telomere repeat intensity,RIP1-Tag2 and K14-HPV16 mice
p  0.001; both by a two-sample t test, assuming equal variances.)To analyze the contributions of telomerase activity to the tumor
D: Centromere-normalized telomere length in G1, G5, and G6 terc/mousebiology and malignant progression of pancreatic islet  cells,
epidermis. The telomere hybridization intensity in each tissue section of G5
terc/ SV129  B6 F1 mice were backcrossed to C57Bl/6J and G6 terc/ mouse skin was first normalized to its cognate centromere
mice, and then crossed to produce generation one (G1) terc/ probe, averaged, and then renormalized to the intensity of similarly normal-
ized telomeres in G1 terc/ mouse epidermis. The difference in relativeRIP1-Tag2 mice. G1 terc/ RIP1-Tag2 mice were mated to
telomere length between G5 and G6 is clearly distinguishable.terc/ mice to produce successive generations of telomerase
deficient (G2 through G7) mice, each with shorter constitutional
telomeres. Mice at G5–7 developed sterility, leading to repro-
ductive failure and termination of breeding at G7. Prototypical
signs of systemic telomere dysfunction (Lee et al., 1998) were
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transgenic mice inbred into FVB/n. Terc/ K14-HPV16 mice
were interbred for successive telomerase null generations until
sterility terminated the line at G7. The late-generation terc/
K14-HPV16 mice showed organismic hallmarks of telomere
dysfunction (Figure 1A and data not shown).
Loss of telomerase function resulted in successive shorten-
ing of telomere lengths, reflected in the content of telomeric
repeat sequences quantified by slot-blot analysis of genomic
DNA using a telomere-specific probe, and by quantitative fluo-
rescence in situ hybridization (Q-FISH) analysis of tissue sec-
tions. The slot blot analysis revealed reductions in mean telo-
mere content in normal tissues from both terc/ RIP1-Tag2 and
terc/ K14-HPV16 mice (Figure 1B). In situ hybridization to
tissue sections of normal liver from wt HPV16 and G5-7 terc/
K14-HPV16 mice using a labeled telomere repeat probe re-
vealed no statistically significant difference in the number of
telomeres comparing wt and terc/ liver; there were, however,
evident reductions in average telomere length, as ascribed by
the hybridization intensity to the telomere repeat probe, when
comparing the wt versus G6/7 liver (Figure 1C). To substantiate
the sensitivity of the Q-FISH methodology, we performed dual-
color Q-FISH using differently labeled centromere and telomere
repeat probes, enabling the telomere hybridization intensity to
be normalized to that of the centromeres (O’Sullivan et al., 2004).
Analysis of three human mammary cell lines of known telomere
length demonstrated a good correlation between the centro-
mere-normalized telomere intensity and the actual telomere
length, indicating that the method could detect 2 kb differences
in average telomere length (Supplemental Figure S1 at http://
www.cancercell.org/cgi/content/full/6/4/373/DC1). A similar
comparative analysis of the epidermis in skin biopsies of terc/
Figure 2. Unaltered pancreatic islet tumor phenotype in G6–7 terc/, RIP1- mice of G1, G5, and G6 (lacking the HPV16 oncogenes) showed
Tag2 mice a progressive decrease in centromere-normalized telomere
A: Tumor burden was determined in the pancreas of 5 terc/ and 5 wt length, and further demonstrated that G5 versus G6 lengths
mice, as described in the Experimental Procedures and methods.
were clearly distinguishable (Figure 1D). Thus both DNA blotB: The tumors were classified as insulinomas, namely islet tumors with well-
hybridization and Q-FISH documented that the telomeres weredefined margins with or without capsules, or as islet carcinomas with focal
(type 1) or widespread invasion (type 2). Tumors were graded by histopa- shorter in G5–7 tissues than in wt or G1 tissues, as expected.
thology using H&E staining of pancreases from 4 terc/ and 5 wt mice at Further, the Q-FISH analysis showed that similar numbers of
13.5 weeks. telomeres were detected in the G5–7 liver (Figure 1C); this result,
C: The proliferation and apoptotic rates were determined in an analysis of
as well as the minimal standard error in the centromere normal-tumors in 5 terc/ mice, compared to 5 wt mice.
ization of G5/6 epidermis (Figure 1D), indicate that virtually allD: Mean telomere length for G0–3 and G5–7 terc/ RIP1-Tag2 tumors was
quantified by DNA blotting with a telomere probe as described in the Experi- chromosomes had detectable telomere repeat structures, de-
mental Procedures. Normal tissue (NT), both spleen (shown) and tail (not spite the five to seven generations of telomere shortening ef-
shown), as well as tumor tissue (T) showed a statistically significant decrease
fected by the absence of telomerase.in mean telomere length in G5–7 terc/ mice versus wt terc/ RIP1-Tag2
mice (p  0.0221 for spleen [NT] tissue comparison; p0.0001 for tumor
tissue comparison). No impact of telomerase deficiency and shortened
telomeres on islet carcinogenesis in RIP1-Tag2 mice
We examined multiple parameters of neoplastic progression in
G5–7 terc/ RIP1-Tag2 mice. RIP1-Tag2 mice develop pancre-
observed in the form of reduced body size and organ atrophy, atic insulinomas and islet carcinomas, and die of tumor burden
particularly in the testes (Figure 1A) and spleen (not shown). In and hyperinsulinemia at about 14 weeks of age (Christofori and
addition, consistent with previous observations (Rudolph et al., Hanahan, 1994). There was no apparent change in the tumor
1999), G5–7 terc/ mice developed abnormalities of the skin, phenotype of terc/ RIP1-Tag2 mice from G1 to G4 (not shown).
including hair loss and dermatitis, and slow wound healing, Beginning at G5, when terc/ mice evidence widespread telo-
indicating that telomere shortening and presumed dysfunction mere dysfunction (Lee et al., 1998), the tumor phenotype was
was impairing skin homeostasis. thoroughly analyzed. Remarkably, there was no significant dif-
K14-HPV16 transgenic mice spontaneously develop squa- ference in tumor burden comparing wt RIP1-Tag2 and terc/
mous carcinomas specifically in the FVB/n background (Cous- RIP1-Tag2 mice near endstage at 13.5 weeks of age (Figure
sens et al., 1996). Thus, to assess the contributions of telome- 2A), nor was their brief lifespan affected (not shown). However,
rase, terc/ mice were first backcrossed into the FVB/n genetic a trend toward lower mean tumor volumes can be discerned in
late generation terc/ mice (Figure 2A). A similar histologicalbackground for 4 generations, and then mated with K14-HPV16
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Figure 3. Similar squamous carcinoma phenotype in G6–7 terc/, K14-HPV16 mice
A: The temporal appearance of invasive squamous cell carcinomas of the epidermis in cohort of 76 terc/ HPV16 mice is shown, in comparison to 65 wt
HPV16 mice over a 12-month period. By the defined endpoint of 12 months, 50% of the HPV-16 Terc/ mice and 65% of HPV-16 terc/ mice had invasive
cancers of varying grades. The earlier onset profile for G6–7 terc/ HPV mice is statistically significant by log rank analysis (p  0.0001).
B: The spectrum of tumor grades ascertained by the progressive loss of squamous differentiated features is shown, revealed by H&E staining of 22 wt and
58 terc/ tumors.
C: The average proliferation index in Grade II squamous cell tumors is shown, in a comparison of 7 wt and 8 terc/ tumors.
D: The apoptotic rates were quantified for hyperplastic and dysplastic lesions, and for tumors from 6 wild-type and 6 terc/ mice. The slight increase in
proliferation rate was borderline for statistical significance (p  0.037) by the Mann-Whitney test; otherwise there were no significant differences.
E: Mean telomere content for HPV16 wild-type and terc/ tumors was quantified by DNA blot hybridization. Nontumor (NT) and tumor (T) tissue showed
a reduction in mean telomere length, but the differences were not statistically significant.
F: Quantitative telomere-repeat FISH revealed a modest increase in telomere number (consistent with increased ploidy—see Figure 7) in G6–7 terc/
compared to wt tumors (left panel, p  0.044 using a two-sample t test, assuming equal variance) and a clear reduction in average telomere length in
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spectrum of tumors (Lopez and Hanahan, 2002) was observed, pearance of epidermal squamous cell cancers (Figure 3A). Appli-
cation of a grading scheme for squamous cancers based onincluding “islet tumors” (IT) with well-defined margins and often
a fibrous capsule, as well as “islet carcinomas” with focal (class loss of keratinocyte differentiation markers (Coussens et al.,
1996, 2000) revealed that G6-7 terc/ mice had a similar distri-1; IC-1) or widespread (class 2; IC-2) invasion of exocrine pan-
creas (Figure 2B). Terc/ RIP1-Tag2 tumors showed similar bution of grade I–IV tumors, with a slight tendency toward
higher-grade lesions (Figure 3B). There was also a modest butrates of apoptosis compared to wt RIP1-Tag2 mice, as assayed
by TUNEL, while similar levels of proliferation were detected by statistically significant increase in proliferation rates for invasive
squamous cell carcinomas of late generation terc/ relative toPCNA staining (Figure 2C).
This similarity of tumor phenotypes led us to investigate the wt K14-HPV16 mice. A marked increase in the frequency of
apoptotic cells was detected in a subset of the G5–7 terc/mean telomere lengths in the tumors, since one interpretation
of the results would be the maintenance of telomere length by invasive carcinomas; by contrast, there was no significant differ-
ence in apoptotic rates in precursor lesions (Figure 3D). DNAsome form of an ALT mechanism. In human cells, the estab-
lished ALT mechanism, based on homologous recombination blotting revealed similar mean telomere repeat content in
Terc/ and terc/ tumors, which was modestly reduced com-to extend telomere lengths, is typically evidenced by relative
increases in average telomere repeat content per cell, and by pared to normal tissues of the same mouse (Figure 3E). Telo-
meres were readily detected by telomere repeat FISH, as exem-considerable heterogeneity in the telomere intensities seen
within a nucleus (Dunham et al., 2000; Henson et al., 2002). In plified in Figure 3G. Quantitative image analysis of telomere
repeat hybridization signals within several hundred nuclei perthe mouse, this classical ALT telomere pattern has been seen
in extensively passaged terc/ transformed fibroblasts (Chang tumor tissue section demonstrated that G5–7 terc/ squamous
carcinomas had a modest increase in number of telomereset al., 2003); additionally, apparent telomere length stabilization
without such variable extension has been reported in late pas- detected per nucleus in these semi-thin sections (reflecting in-
creased ploidy amongst the tumors analyzed—see below).sage terc/ cell cultures (Hande et al., 1999). We determined
mean telomere content by DNA blot hybridization of DNA iso- Much as for the comparison of liver (Figure 1C) and epidermis
(Figure 1D) from “normal” terc/ mice (lacking the HPV16 trans-lated from pancreatic islet tumor biopsies with a telomere repeat
probe. The analysis revealed modest reductions in mean telo- gene), we saw clear reductions in the average telomere length
in G6–7 tumors (Figure 3F). Importantly, the variance in telomeremere content in terc/ G5–7 islet tumors compared to wt RIP1-
Tag2 tumors, as well as in comparison to normal spleen DNA intensities was not markedly different between wt and G6–7
tumors, nor between tumors and liver in the same telomerase(Figure 2D) and tail DNA (not shown) in the same G5–7 terc/
animals. The data are not diagnostic of the classical ALT-medi- null mice (Figure 3E). Both parameters argue against induction
of the classical recombination-based ALT pathway, which isated stabilization of telomeres that markedly increases mean
telomere lengths. characterized by heterogeneously lengthened telomeres (Dun-
ham et al., 2000; Henson et al., 2002; Chang et al., 2003).
The minimal effect on skin carcinogenesis is remarkable whenConsequences of telomere shortening on squamous
carcinogenesis in K14-HPV16 mice considering the 6–10 month period of proliferative hyperplasia
and dysplasia that precedes malignant conversion and growthK14-HPV16 transgenic mice spontaneously develop epidermal
squamous cell carcinomas between 6–12 months, reaching a of large protuberant tumors.
50% incidence at 12 months (Coussens et al., 1996). Multifo-
cal epidermal hyperplasia ensues at 1–2 months, developing No chromosomal instability in telomere-shortened
G5–7 RIP1-Tag2 or K14-HPV16 terc/ tumorsinto focal, highly proliferative, angiogenic dysplasias from 3–6
months, one of which typically progresses to an invasive carci- One interpretation of the lack of major effects on tumor pheno-
type in these two distinctive models is that the tumors arenoma by 12 months. The other foci of dysplasia in tumor bearing
mice, as well as the dysplastic lesions in mice that do not tolerant of genomic disarray and aneuploidy resultant from telo-
mere dysfunction, as a result of the oncogene-induced defi-develop cancer by one year, continue in a highly proliferative
condition without apparent lesional regression or progression. ciencies in the p53 and pRb cell cycle checkpoints. An alterna-
tive interpretation is that the telomeres are not criticallyAs such, we anticipated continuing telomere erosion in the ab-
sence of telomerase in lesions with a high proliferation index dysfunctional in the hyperproliferative dysplasias and tumors,
despite the absence of telomerase and the clear evidence for(30%–50% of keratinocytes) over a period of 6–10 months.
There was no apparent alteration in tumor phenotype for terc/ telomere dysfunction in normal tissues. Notably, evaluation of
mean telomere lengths in normal and tumor tissue of G6–7 miceK14-HPV16 mice in the early telomerase null generations, much
as for the terc/ RIP1-Tag2 mice. Detailed analyses were per- in both models revealed further telomere shortening in tumors
relative to the “ground state” length in normal telomerase nullformed on G5–7 mice, which revealed no impairment of the
cancer phenotype, but rather indications of a slightly more ag- tissues (Figures 2D and 3E). Since p53 is abrogated by the viral
oncogenes in both models, we predicted, based on observa-gressive disease. G6 and G7 terc/ K14-HPV16 mice showed
a modest but statistically significant shift toward an earlier ap- tions in p53-deficient terc/ mice (Artandi et al., 2000), that
the G6–7 tumors, as inferred by the intensity of telomere repeat hybridization in an analysis of all discrete telomeres in 100 nuclei each of 4 tumors (right
panel, p  0.002 using a two-sample t test, assuming equal variance).
G: Representative images of nuclei in tumor sections analyzed by telomere repeat FISH, comparing a terc/ (left) with a G7 terc/ (right) squamous
carcinoma. Both images were obtained with a 63 objective and are shown at the same magnification; the white bar indicates 10 m.
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Figure 4. Anaphase bridge analysis is not indicative of increased mitotic
dysfunction in late generation telomerase null tumors
The anaphase bridge index in tumors of RIP-Tag2 and HPV16 models was
determined as described in the Experimental Procedures, based on com-
parative analysis of 12 terc/ versus 11 wt terc/ RIP1-Tag2 islet tumors,
and of 5 terc/ versus 5 wt terc/ K14-HPV16 tumors. The differences were
not statistically significant.
genomic instability would be induced by critically short telo-
meres. We addressed this hypothesis in multiple ways. First,
we assessed the incidence of anaphase bridges in wt versus
G6–7 tumors in each model. Anaphase bridges reflect aberrant
chromosomal segregation during mitosis, a marker of telomere
dysfunction in yeast (Kirk et al., 1997) and in mouse and human
tumors (Rudolph et al., 2001). A slight increase in the anaphase
bridge index (ABI) is evident in normal tissues of terc/ relative Figure 5. Comparative genomic hybridization analysis of wt versus terc/
pancreatic islet tumorsto wt RIP1-Tag2 mice. There was, however, no significant differ-
ence in anaphase bridge frequency comparing wt versus G6–7 A: The genome-wide CGH array profile is shown for an islet carcinoma in
a G5 terc/ RIP1-Tag2 mouse, which reveals losses on chromosome 16,islet cell tumors (Figure 4A). Similarly, there was no significant
typical of such tumors in wt RIP1-Tag2 mice (Hodgson et al., 2001). The logdifference in ABI between wt and G6–7 K14-HPV16 mice in
(cy3/cy5 fluorescence intensity ratio) of quadruplicate measurements per
either normal skin (not shown) or in squamous carcinomas (Fig- clone is plotted on the y axis. Clones are arranged along the x axis by
ure 4B). Since the dysplasias in the skin of the K14-HPV16 mice chromosome (gray vertical bars delimit the chromosome boundaries);
within each chromosome, clones are arranged by their position in the as-can exist for 6–10 months in a highly proliferative condition
sembled mouse genomic sequence.without regressing or progressing, we assessed the ABI in a
B: Frequency of copy number abnormalities (CNA) in wt RIP1-Tag2 tumors.set of hyperplasias and dysplasias from wt and G6–7 terc/
C: Frequency of CNA in G1–3 terc/ RIP1-Tag2 tumors
mice; the lesions were collected from mice ranging from 6–12 D: Frequency of CNA in G6–7 terc/ RIP1-Tag2 tumors.
months of age for both wt and terc/. Again, there was no
appreciable difference in ABI between the wt group and the
G6–7 terc/ group (Figure 4B). Both terc/ and wt groups
evidenced a marked increase in ABI in dysplasia relative to early chose to assess disruptions in the integrity of tumor genomes
by profiling genomic copy number abnormalities (CNAs) usingstage hyperplasia, and both had increased numbers of aberrant
mitotic figures and anaphase bridges in carcinomas. Collec- array-based comparative genomic hybridization (Hodgson et
al., 2001; Pinkel et al., 1998; Pollack et al., 1999). Eighteen G6–7tively, by the criterion of anaphase bridge frequency, we found
no evidence for differential mitotic aberrations in neoplastic le- terc/ RIP1-Tag2 tumors were analyzed, along with 13 tumors
from G1–3 terc/ RIP1-Tag2. In line with previous studies,sions of late generation terc null mice relative to wt mice, despite
concurrent hallmarks of organismic telomere dysfunction. recurrent regional gains and losses were observed, but wide-
spread copy number abnormalities were not detected. Figure 5ANext, we sought to assess the degree of genomic alterations
as an indicator for the prevalence of genome instability in the shows an array-CGH array profile of one such tumor, revealing a
typical loss on mouse chromosome 16. The frequencies of gainstelomerase-deficient and control tumors. Given the constraints
posed by the sterility and inability to maintain lines of late gener- and losses across the genome are shown for wt RIP1-Tag2
tumors (Figure 5B), for G1–3 terc/ RIP1-Tag2 tumors (Figureation telomerase null RIP1-Tag2 and K14-HPV16 mice, we
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Figure 6. Comparative genomic analysis of wt versus terc/ skin tumors
A: A genome-wide scan of a squamous carcinoma in a G6 terc/ K14-HPV16 mouse. Plot details are given in Figure 5. High-level amplification on
chromosome 6 is evident. This region was amplified in 4/10 terc/ tumors, but amplifications were not detected by CGH array analysis of 6 wt tumors.
Gain of a small region of chromosome 3 is also apparent; this region was gained in all wt and terc/ K14-HPV tumors examined. The increased fluorescence
ratio of the X chromosome clones is reflective of the sex mismatch of the test (tumor) and reference genomes.
B: Frequency of CNA in wt K14-HPV16 tumors.
C: Frequency of CNA in G5–7 terc/ K14-HPV16 tumors.
D: A detailed view of the chromosome 6 amplicon in 3 primary skin tumors (i–iii). Gray bars in the schematic shown at the bottom of the figure indicate
regions that are commonly amplified (2 fold) in all 3 tumors. Genes of interest mapping to this region are shown in addition to their corresponding syntenic
human locus. K-ras2 maps to the region of highest amplification in 2/3 tumors. Pik3c2G also maps to the common region. The tumor suppressor Cdkn1b
(p27) is clearly maintained at normal levels in the tumor shown in ii, despite amplification of proximal and distal sequences.
5C), and for G6–7 terc/ RIP1-Tag2 tumors (Figure 5D); all detectable in the form of widespread copy number abnormali-
ties using array CGH (O’Hagan et al., 2002). Thus, these viralrecurrent CNAs were at loci previously identified in the wt RIP1-
Tag2 tumors (Hodgson et al., 2001). The frequency of LOH16 oncoprotein-driven telomerase-deficient neuroendocrine tu-
mors are not suffering generalized telomere dysfunction andwas slightly increased, to80% in the G6–7 tumors; by compar-
ison, the frequency of LOH16 in the wt and G0–3 mice ranged consequent genomic disarray.
We next analyzed 10 skin tumors from G6–7 terc/, K14-from 60%–70%. There was no suggestion of more widespread
genomic alterations in these tumors. It is pertinent to recognize HPV16 mice using array CGH, in comparison to 6 tumors from
wt K14-HPV16 mice. As for the islet tumors, there was no evi-that the array CGH technology employed here will only detect
copy number changes that are present in more than about dence for widespread disruptions in genomic integrity, consis-
tent with the similar ABI (Figure 4B) comparing G6–7 and wt40% of the cells populating a tumor (Hodgson et al., 2001).
Nevertheless, array CGH is capable of detecting the rampant tumors. A representative tumor profile is shown in Figure 6A.
The frequency profile of CNA across the genome is shown foraneuploidy characteristic of many human tumors, because
clonal selection for particular CNAs likely carries along other wt K14-HPV16 tumors (Figure 6B) and G6–7 terc/, K14-HPV16
tumors (Figure 6C). Frequent losses (80%) and gains (100%)random genomic alterations that are not recurrent from tumor
to tumor (Pinkel et al., 1998; Pollack et al., 1999). Moreover, were detected in different parts of the distal end of chromosome
3 in both G6–7 terc/ and wt K14-HPV16 tumors. Interestingly,analysis of tumors in late generation terc/, p53/ mice pre-
viously revealed aneuploidy similar to that observed in human we observed a local amplification (2 fold) on the distal end of
chromosome 6 in 4/10 telomerase null tumors (Figure 6C); twotumors, in the form of end-to-end chromosomal fusions (Artandi
et al., 2000); the aneuploidy in those mouse tumors was also of these were a primary skin tumor and a lymph node metastasis
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Figure 7. Copy number analysis of a typical chro-
mosome (Chr. 2) detected in semi-thin sections
from squamous cell carcinomas in HPV16 mice
by FISH
A: The G5–7 tumors are predominantly tetra-
ploid, a conclusion based on the mean copy
number of Chr. 2 detected in thin sections, since
the analysis involved 4  sections that covered
about 60% of an intact nucleus. G3–4 tumors
were typically diploid or triploid, while wt tumors
are generally diploid (an exception is tumor #1,
which is tetraploid).
B: Statistical analysis of the variance in chromo-
some 2 copy number in populations of cells in
tumors of the noted terc genotypes. Beyond the increase in ploidy, the variance (and the variance of the variance) is not significantly different among
the groups. A significant difference would have been indicative of genomic instability in a subset of the cells in a particular population.
from the same animal, and both contained the same amplicon. ance of the variance, were similar (Figure 7B). This analysis
does not therefore indicate a differential incidence of episodicNo such amplification was observed in the 6 wt HPV tumors
analyzed herein by array CGH, nor in two independent series instability for chromosome 2, chosen as an unbiased marker
chromosome, in the late generation telomerase null tumors thatof wt tumors analyzed either by traditional CGH to metaphase
chromosomes (D. Pinkel and J. Arbeit, personal communication) might have been indicative of telomere dysfunction.
or by array CGH to microdissected carcinoma cells (L. Coussens
et al., personal communication). The copy number increases Evidence for telomere functionality in G5–7
pancreatic tumorsobserved on the distal end of chromosome 6 in wt HPV16
tumors (Figure 6B) consisted of low copy gains. A detailed view Further support for the conclusion that the G5–7 tumors largely
contain cells with functional telomeres on their chromosomesof the chromosome 6 amplicon, syntenic with human 12p11-
p13, reveals a complex genomic pattern (Figure 6D). K-ras2 comes from a study involving serial transplantation of G5–7 islet
tumors. Three small tumors (from a G5, a G6, and a G7 terc/,maps to the copy number peak in tumors with the highest level
(8 fold) of amplification, although one tumor did not contain RIP1-Tag2 mouse, respectively) with tumor volumes of 8, 12,
and 27 mm3, were inoculated into immunodeficient (Rag1 null)K-ras2 in its amplicon (Figure 6D). Interestingly, in an analysis
of breast, colon, and skin cancers than arose in late generation mice. In each case, a transplant tumor of 100 volume arose
(data not shown). In two cases,10 mm3 pieces of the transplantterc/ p53/ mice, array CGH revealed a high frequency of
amplification of this same region on chromosome 6 (O’Hagan tumor were serially passaged into new rag1/ mice, and again
tumors of 100 volume arose (Table 1). Thus, the G5–7 isletet al., 2002).
Since CGH detects recurrent copy number changes in the tumors still possessed robust replicative potential.
ensemble of cells in a tumor, it cannot exclude the occurrence
of sporadic genomic instability resultant from dysfunctional telo- Telomere stabilization during squamous
carcinogenesismeres in a minor subset of those cells. To address the possibility
of episodic instability, we performed FISH analysis of a set of Additional evidence for telomere length maintenance came from
comparing relative telomere lengths in the stages of skin carci-squamous cell carcinomas using a probe to chromosome 2,
which shows infrequent abnormalities by array CGH (Figure 6). nogenesis in G6–7 terc/ HPV16 mice. Proliferative hyperpla-
sias develop at 1 month and progress to dysplasias by 3–6The rationale was that abnormalities in the number of copies
of chromosome 2 per nucleus would be indicative of nonspecific months, which in turn can progress to invasive squamous tu-
mors after persisting in this hyperproliferative condition for upepisodic instability in the population of tumor cells; indeed, an
analogous experimental design applied to the stages in human to 9 months. Genetic analyses indicate that dysplasias are pro-
genitors to the tumors and that both are clonal by virtue ofbreast carcinogenesis revealed just such chromosomal instabil-
ity (Chin et al., 2004). We evaluated 100 nuclei from wt, G3–4, containing recurrent chromosomal abnormalities in a majority
of cells (L. Coussens, personal communication). Thus, hyper-and G5–7 terc/ HPV16 tumors (n  3, 4, and 8 each, respec-
tively). From the average numbers of chromosomes 2 signals proliferation leading to these tumors lasts 10 months on average
and involves at least one clonal selection. The prediction, there-detected in thin (4 m) sections representing 60% of the
nucleus, we determined that the wt tumors were with one excep- fore, is that telomeres should continue to erode during squa-
mous cell carcinogenesis in a G5–7 terc/ HPV16 mouse. Totion diploid or triploid, as were the G3–4 tumors; the G5–7
tumors were mostly tetraploid (Figure 7A). These differences address this expectation, tissue sections of hyperplastic skin,
dysplastic skin, and tumor from the same animal were placedare reflective of the overall chromosomal ploidy in these tumors
(not shown). There was no statistically significant difference in side by side on a glass slide, hybridized with a telomere repeat
probe, and the hybridizations (exemplified in Figure 3G) cap-the frequency of nuclei with abnormal numbers of chromosome
2 compared to the mean among the tumors from the three terc tured digitally. The digital images were subjected to quantitative
image analysis involving at least 100 nuclei per stage; bothgenotypes (Figure 7B); typically, a few percent of the nuclei in
each terc/ genotype had 2 the average copy number of the oncogene-expressing hyperproliferative keratinocytes and
adjacent stroma (reactive dermis) were evaluated. In addition,chromosome 2 (i.e.,  G2 numbers). The average number of
chromosome 2 detected, as well as the variance, and the vari- we analyzed both epidermal keratinocytes and adjacent dermal
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Table 1. Tumor transplantation experiment demonstrating further proliferative capacity of G5-7 terc/ RIP1-Tag2 tumors
Origin of tumor
material transplanted Size of transplanted tumor Terc/ generation Tumor growth of transplant (dia.) Notes
RT2, Terc/ (#92066) 2.5 mm dia. intact tumor G5 1 cm First serial passage
RAG1/ transplant 3 mm3 fragment 1.2 cm Serial (2	) passage
RT2, Terc/ (#“TO1”) 3 mm dia. intact tumor G6 1 cm First serial passage
RAG1/ transplant 3 mm3 fragment 1.2 cm Serial (2	) passage
RAG1/ transplant 3 mm3 fragment 0.5 cm Serial (2	) passage
RT2, Terc/ (#95211) 2 mm dia. intact tumor G7 0.6 cm First serial passage
RT2, Terc/ (#95211) 2 mm dia. intact tumor G7 0.8 cm First serial passage
fibroblasts in wt and G5–7 terc/ skin of mice lacking the K14- centromere-telomere FISH was used to normalize telomere
length (and variance) to the centromeres both in comparisonsHPV16 transgene.
We used two methods performed in independent labora- of (1) three human cell lines of known telomere length (Supple-
mental Figure S1) and (2) the epidermis in skin biopsies of G1,tories, one a variation on the method of Lansdorp (Poon and
Lansdorp, 2001), and the other an independent algorithm (Ortiz G5, and G6 terc/ mice lacking the K14-HPV16 transgene
(Figure 1D); in each analysis, Q-FISH detected telomere shorten-de Solo´rzano et al., 1999); both are described in the Supplemen-
tal Data at http://www.cancercell.org/cgi/content/full/6/4/ ing, consistent with expectations. Furthermore, Q-FISH de-
373/DC1. Each method produced similar results. Four case tected telomere erosion in pairwise comparisons of wt tel-
studies performed on lesional stages from individual mice are omerase-proficient versus G5–7 telomerase null normal liver
shown in Figure 8A. In addition, the average telomere intensities cells (Figure 1C) and wt versus G5–7 tumor cells (Figure 3F).
for each stage from the four cases were combined and averaged To address another possibility, that chromosomes with criti-
(see Cases Combined panel); also shown in this panel is a similar cally shortened telomeres (or lacking telomere-repeats alto-
determination of the average telomere intensity of keratinocytes gether) were present but simply undetectable by our methods,
in age- and generation-matched terc/ mice lacking the HPV16 we quantitated the number of telomeres and centromeres per
oncogenes. Notably, the dermal fibroblasts had greater telo- nucleus. If telomeres were becoming lost/undetectable, then
mere intensity than the adjacent epidermal keratinocytes in the the modal telomere number should decline with progression,
G5–7 terc/ mice lacking the HPV16 oncogene-induced neo- particularly when normalized to the centromere number. By
plasia, indicative of greater telomere erosion in the squamous contrast, the analysis revealed increasing numbers of telomeres
epithelium of the epidermis, wherein progenitor cells (transient in the neoplastic keratinocytes, which scaled with the number
amplifying cells) undergo cell division throughout life. Similarly, of centromeres detected in all stages (Figure 8B). We infer that
the keratinocytes in all neoplastic stages had lower telomere this increase in telomere number correlates with the modal chro-
intensities than the stromal fibroblasts adjacent to the hyperpla- mosome number, given that the G6–7 tumors were tetraploid,
sias (cases 1–4, Figure 8A). Surprisingly, the data do not reveal as documented by FISH to chromosome 2 (Figure 7), and that
reductions in average telomere length per nucleus in the pro- the telomere density per unit nuclear area was constant (Supple-
gression from hyperplasia to dysplasia to clonal tumor. There mental Figure S2). Thus, there was no indication that telomeres
appears to be a slight reduction in keratinocyte telomere inten- were being lost or shortened below the limits of detection by
sity of all neoplastic stages in comparison to normal skin kera- FISH, in particular during clonal expansion leading to large solid
tinocytes from G5–7 terc/ mice lacking the HPV16 oncogenes tumors. Moreover, the variance in hybridization intensity per
(Cases Combined, Figure 8A), but the difference is not statisti- telomere did not increase substantively during progression,
cally significant. We further substantiated this conclusion in a even when the telomere length intensity was normalized to that
dual-color FISH analysis involving cohybridization with a centro- of the centromeres (Figure 8B). We would have expected to see
mere repeat probe to visualize every chromosome, irrespective a high variance in average telomere repeat intensity, either per
of whether it had detectable telomeres. The intensity of each chromosome or per nucleus, if a subset of telomeres were
centromere in a nucleus section was determined and combined becoming differentially shortened, and/or markedly lengthened
to give an intensity value, which was then used to normalize (e.g., by the recombination-based ALT mechanism). Rather,
the analogous telomere intensity value for that nucleus. A mean there was little change in average telomere intensity or variance
normalized telomere value was then established for200 kera- in the stages of squamous carcinogenesis in G6–7 terc/HPV16
tinocytes of a particular stage, with the dysplasias and SCCs mice, either in the single color Q-FISH analysis (Figure 8A) or
further normalized to the value of the hyperplasia, which we in the centromere-normalized analysis (Figure 8B).
infer had had a shorter proliferative lifespan. The analysis of 2
of the cases shown in Figure 8A revealed a modest increase Discussion
in centromere-normalized telomere intensity in one case, and
largely unchanged levels in the other; in neither case was a In this study, the necessity of telomerase activity for multistage
tumorigenesis has been investigated in two distinctive mousereduction in telomere intensity evident upon clonal outgrowth
of the dysplasias and carcinomas (Figure 8B). models, of skin and pancreatic islet carcinogenesis. When the
mice were bred successively in the telomerase null backgroundThese conclusions rest upon the sensitivity of the Q-FISH
methodology employed in our study, and multiple lines of evi- to produce shortened telomeres more analogous to humans,
only modest effects were seen on tumor phenotype. There wasdence indicate that it is sensitive and quantitative. Dual-label
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Figure 8. Comparison of telomere intensities in
the stages of squamous carcinogenesis of G5–7
HPV16 mice
A: Four case studies are shown, in which tissue
sections representing hyperplastic skin (Hyp),
dysplastic skin (Dys), and squamous cell carci-
noma (SCC) from the same animal were placed
on the same microscope slide, hybridized to-
gether to a telomere repeat probe, digitally
captured in a fluorescence microscope, and
analyzed by two independent quantitative im-
age analysis algorithms. Neoplastic epithelial
cells (keratinocytes) populating the epidermis
or tumors were quantitated, as were the adja-
cent stromal/dermal fibroblasts in the hyperpla-
sia biopsies. Each method (see the Supplemental
Data at ht tp://www.cancercel l .o rg/cgi/
content/full/6/4/373/DC1) produced similar re-
sults, and those from method 1 are shown, with
the y axis indicating the average telomere re-
peat intensity value per nucleus. The lower panel
(Cases Combined) shows the average intensity
value of a given stage from the four HPV16 mice,
as well as the average intensity from a similar
analysis of the keratinocytes in normal skin biop-
sies (NS) of three similarly aged G5–7 terc/ mice
that lack the K14-HPV16 transgene.
B: A dual-color centromere-telomere Q-FISH
method (see Experimental Procedures and Sup-
plemental Figure S1) was used to reanalyze two
cases (#122083 and #113816) to substantiate the
result that telomere lengths were modestly in-
creased in the latter stages of progression, and
to assess a possible inability to detect with this
Q-FISH method an increasing frequency of chro-
mosomes that lack detectable telomere re-
peats. The relative intensity of telomere to cen-
tromere repeat hybridization per nucleus and
then per 200 nuclei was calculated, and the
values of dysplasia and cancer were further nor-
malized to the intensity of hyperplasia. In the
lower panels, the numbers of telomeres and of
centromeres were quantitated and averaged
for each stage, and then normalized to the hy-
perplastic stage. Finally, the average telomere
number per stage was normalized to the centro-
mere number, and again to the hyperplastic
stage. This analysis indicates that telomere drop-
out or lack of detectability is not a frequent oc-
currence in the lesional stages, since if it was,
the ratio would drop, and the variance would
increase.
no evidence for genomic manifestations of telomere dysfunction suppressor, which functions as a DNA damage sensor, forcing
cells with broken chromosomes into G1 arrest or apoptosis. Inin the cells populating neoplastic and malignant lesions in the
two models. Collectively, the data support the conclusion that gene knockout mice for the tumor suppressors Ink4a/Arf or APC,
where p53 damage-sensing function was intact, late generationthe neoplastic cell populations did not suffer from appreciable
telomere dysfunction, despite the absence of telomerase and terc/ mice had reduced frequencies of cancer and increased
survival (Greenberg et al., 1999; Rudolph et al., 2001). Similarly,consequently shortened telomeres that were concomitantly pro-
ducing aberrations in normal tissues of the same tumor-bearing skin tumorigenesis was reduced in terc/ mice subjected to a
classical 2-stage carcinogenesis regimen (Gonzalez-Suarez etmice.
Our results stand in provocative contrast to previous studies al., 2000). On the other hand, in mice where p53 function was
directly abrogated by gene disruption, late generation terc/in other telomerase-deficient cancer-prone mouse strains,
which revealed either retarded or substantially altered tumor mice had an altered spectrum of tumors: p53/ and p53/
mice normally develop lymphoid and fibroblastic tumors,phenotypes, underscoring the complexity of telomere dynamics
and telomerase function in neoplastic initiation and progression whereas late generation terc/ p53/ mice developed frequent
epithelial carcinomas concomitant with loss of the wt p53 allele(Chin et al., 1999; de Lange and Jacks, 1999). The prior studies
in mice can be segmented by the status of the p53 tumor (Artandi et al., 2000). Notably, an indirect measure of telomere
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dysfunction, the loss of genomic integrity as assessed by spec- with the archival tissue precluded analogous Q-FISH analysis,
tral karyotyping (Artandi et al., 2000), array CGH (O’Hagan et leaving open the possibility that the ontogeny of islet  cell
al., 2002), or anaphase bridging (Rudolph et al., 2001), indicated development and tumorigenesis is tolerant of progressive telo-
that the tumors lacking both telomerase and p53 had chromo- mere shortening, in lieu of such a means of telomere stabiliza-
somal instability and aneuploidy consistent with critically short, tion. That said, we favor an alternative explanation, namely that
dysfunctional telomeres. a means of preserving telomere function, an “ALT-2” mecha-
Given that p53 is inactivated by viral oncogenes in both of nism, is operative in both of these tumorigenesis pathways.
the models studied here, we expected to see an increase in There are at present no clues into the molecular components
tumor incidence and/or change in tumor phenotype similar to of this apparent mechanism for maintaining telomere function.
the results of Artandi et al. (2000). The actuality was a surprising One possibility is that ALT-2 involves components of the estab-
lack of effect: there was no indication of prevalent telomere lished recombination-based ALT mechanism, but used in a dis-
dysfunction in tumors in either of the models described in this tinctive way that does not invoke the long and heterogeneous
report, dysfunction which should have been revealed either by telomere extensions seen in ALT tumors (Cerone et al., 2001).
increases in anaphase bridge frequency, by nonspecific aneu- This notion is perhaps consistent with the recent observation
ploidy in the form of genome-wide copy number differences
that, in certain human cells deficient in telomerase, the ALT
detectable by array CGH, and/or by specific aneuploidy of a
capability for preserving telomeres does not invoke generalizedtypical chromosome (Chr 2) analyzed by FISH. Nor was there
activation of homologous recombination but rather acts selec-major alteration in tumor grade or proliferation index. A poten-
tively on telomere repeats (Bechter, et al. 2003).tially significant genetic difference between these and the afore-
In conclusion, the data we present clearly implicates amentioned models is the direct functional inactivation of both
means for preserving telomere length and functionality in tumorsp53 and Rb tumor suppressor proteins, much as occurs in many
expressing viral oncogenes that co-opt multiple cellular func-human tumors; the previous models involved targeting either
tions, including both the Rb and p53 tumor suppressors, butone or the other suppressor pathway, or both suppressor path-
does not reveal the mechanistic components that manifest thisways but at different points (Ink4A/p16 and Arf/p19) that may
capability. It seems likely that this mechanism will be amenablenot be functionally equivalent. Moreover, both the SV40 Tag
to clarification in genetically engineered cells in culture; theand the HPV16 E7 oncogenes target suppression of the Rb
sterility of late-generation terc/ mice and our inability to derivefamily at large, inactivating p107 and p130 as well as pRb itself;
cell lines from the tumors limits the potential for these particularit is notable that Blasco and colleagues reported involvement of
mouse models to serve that purpose. Nevertheless, by carefullythe Rb family in telomere maintenance of telomerase-proficient
cells (Garcia-Cao et al., 2002). It must be emphasized, however, analyzing the distinctive stages in tumorigenesis, we have docu-
that both sets of viral oncogenes used in our models (SV40 mented a means for preserving telomere function in the absence
large T and small t, or HPV16 E1–E7) co-opt other cellular func- of telomerase, one that may prove relevant for certain types of
tions, and one or more of their other targets might prove instru- human cancer.
mental in the phenotypes we observe.
Experimental procedures
Another means for telomere maintenance in tumors?
Anaphase bridge indexOur data collectively argue that, despite concurrent dysfunc-
An anaphase bridge is defined as the presence of a bridging chromosometions in other organs (organ atrophy, small body size, sterility),
over at least 2/3 of the distance between two anaphase poles (Rudolph etthe telomeres in developing tumors in pancreas and skin in-
al., 2001). These histological structures represent abnormal chromosomal
duced by these viral oncogenes are somehow maintained in segregation resulting from telomere dysfunction. The anaphase bridge index
their functionality, and their length. Multiple lines of evidence (ABI) is the ratio of anaphase bridges to the total number of anaphases
support this hypothesis: (1) the average telomere intensity, as counted. The ABI was derived from scoring at least 15 anaphases in each
revealed using two independent quantitative image analysis al- tissue of interest in 5 m paraffin sections stained with hematoxylin and
eosin.gorithms of telomere FISH on matched hyperplasias, dyspla-
sias, and squamous carcinomas, was essentially stable, with
Transplantation of G5–7 terc/ islet tumors into Rag1/ miceno evident erosion despite the clonal expansion of the 1 cm
Small (2 to 3 mm diameter) islet cell tumors were excised from terc/diameter tumors; (2) the number of telomeres per nucleus de-
RIP1-Tag2 pancreatic tissue, washed in sterile PBS at 37	C, and implantedtectable by telomere-FISH did not decrease, but rather in-
subcutaneously into the flanks of C3HeBFe strain rag1/ mice (Jackson
creased congruously with modal chromosome number in neo- Laboratory). Prior to implantation, rag1/ mice were anesthetized with an
plasias and tumors; (3) there was no indication of mitotic I.P. injection of 2.5% Avertin solution, and a small slit on the flank was cut
abnormalities and/or widespread genomic instability in either into the skin of the mouse. A pocket under the skin approximately the size
model; (4) the islet tumors in G5–7 mice could be serially trans- of the tumor was enlarged with forceps, and the tumor placed into the pocket.
The slit was then sealed closed using cyanoacrylate adhesive (NexaBand,planted; and (5) there was little phenotypic impact on either
Veterinary Products Laboratories). The implanted mice were observed untilpathway to cancer. While collectively suggesting that the telo-
the tumor was approximately 1 cm in diameter, or until the deterioratingmeres were somehow maintained in length and functionality, the
health of the mouse dictated euthanasia (2–3 months). In either case, thedata do not implicate the classical ALT pathway that produces
mice were sacrificed and the tumor excised and measured. One transplantheterogeneously elongated telomeres, given the stability and
tumor arising from a G5 terc/ RIP1-Tag2 primary tumor and another arising
low variance in telomere intensity and telomere number revealed from a G6 mouse were each serially passaged by placing a 3 mm3 fragment
by the quantitative (and in some cases centromere-normalized) of the s.c. transplant tumor tissue subcutaneously into the flank of a
Q-FISH analysis of the stages in squamous carcinogenesis. In C3HeBFe strain rag1/ mouse, as described above; 1 cm tumors again
arose several months later.regards to the islet tumorigenesis pathway, technical difficulties
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